Research Progress on the Relationship Between Depression and Serum Inflammatory Factors and Their Treatment
10.3870/j.issn.1004-0781.2025.06.011
- VernacularTitle:抑郁症与血清炎症因子的关系及其治疗研究进展
- Author:
Shu YANG
1
;
Xiaolei LIU
;
Licong YANG
;
Shaochuan ZHANG
;
Tianhao BAO
;
Wenlin TAI
Author Information
1. 昆明医科大学第二附属医院检验科,昆明 650011;昆明医科大学附属精神卫生中心(云南省精神病医院)检验科,昆明 650225
- Publication Type:Journal Article
- Keywords:
Antidepressants;
Hydroxyeicosatetraenoic acids;
Depression;
Seruminflammatory factor
- From:
Herald of Medicine
2025;44(6):906-911
- CountryChina
- Language:Chinese
-
Abstract:
Depression is a chronic brain dysfunctional disease mainly due tomood disorders.Currently,the pathogenesis of depression is unclear,and its pathogenesis,pathophysiology and treatment have consistently been a major focus of academic research.This review provides an overview of the role of serum inflammatory factors in the pathogenesis,diagnosis,and treatment of depression.The inflammatory factor pathway provides a theoretical basis for the development of diagnostic and therapeutic methods for depression.It is expected to provide accurate personalized treatment for patients with depression through the treatment of inflammatory factors,improve the treatment outcomest,and reduce the risk of disease progression.
